Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Armata Pharmaceuticals
AddedFeb 19, 2024
UpdatedJun 18, 2026
Armata Pharmaceuticals

Armata Pharmaceuticals

Public

Armata Pharmaceuticals: Innovating biotech solutions for diagnosing, treating, and preventing diseases.

HQ
Marina del Rey, CA, US
Founded
2005
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to combat antibiotic resistance, Armata Pharmaceuticals is a biotechnology company focused on developing innovative phage therapeutics. Their core vision is to provide high-impact, best-in-class solutions for diagnosing, treating, and preventing human and animal diseases. Armata's primary market focus is on addressing the global health challenge posed by antibiotic-resistant infections through precision-engineered bacteriophage therapies.

Notable figures affiliated with Armata Pharmaceuticals include leading scientists and biotech investors committed to advancing phage therapy research. The company has achieved significant milestones in preclinical and clinical development, positioning itself as a pioneer in the field of bacteriophage-based treatments. Armata's impact is marked by its contributions to the scientific community and its potential to revolutionize the treatment of antibiotic-resistant infections, offering hope for more effective and targeted therapies.

Armata Pharmaceuticals - Similar Companies

PhagePro logo

PhagePro

phageproinc.com

Adaptive Phage Therapeutics logo

Adaptive Phage Therapeutics

SmartPhage logo

SmartPhage

Venatorx Pharmaceuticals logo

Venatorx Pharmaceuticals

venatorx.com

Bioharmony Therapeutics logo

Bioharmony Therapeutics

Recida Therapeutics logo

Recida Therapeutics

Atterx BioTherapeutics logo

Atterx BioTherapeutics

atterx.com

Taxis Pharmaceuticals logo

Taxis Pharmaceuticals

taxispharma.com

Biolytx Pharmaceuticals logo

Biolytx Pharmaceuticals

biolytx.com

ArrePath logo

ArrePath

arrepath.com

Armetheon logo

Armetheon

X-Biotix Therapeutics logo

X-Biotix Therapeutics

Arbutus Biopharma logo

Arbutus Biopharma

arbutusbio.com

Armis Biopharma logo

Armis Biopharma

armisbiopharma.com

Phyla logo

Phyla

phylabiotics.com

Armata Pharmaceuticals - Quick Facts

Who are Armata Pharmaceuticals' competitors?

Companies similar to Armata Pharmaceuticals include PhagePro, Adaptive Phage Therapeutics, SmartPhage and Venatorx Pharmaceuticals.

When was Armata Pharmaceuticals founded?

Armata Pharmaceuticals was founded in 2005.

Where is Armata Pharmaceuticals' headquarters located?

Armata Pharmaceuticals' headquarters is located in Marina del Rey, CA, US.

When was Armata Pharmaceuticals' last funding round?

Armata Pharmaceuticals' most recent funding round was for $25M (USD) in July 2023.

How much has Armata Pharmaceuticals raised to-date?

As of Jul 11, 2023, Armata Pharmaceuticals has raised a total of $251M (USD).

How many employees does Armata Pharmaceuticals have?

Armata Pharmaceuticals has 77 employees as of Feb 6, 2024.

Armata Pharmaceuticals - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
  • Government
Main Product
  • Phage Therapeutics
Tags
  • Healthtech
Unique IDs
  • ein: 911549568
  • secCik: 0000921114
  • ticker: ARMP
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2836Biological Products, Except Diagnostic Substances
  • 2800Chemicals And Allied Products
  • 2830Drugs
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325414Biological Product (except Diagnostic) Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research